Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatch study tests if AI can boost Pill-Taking in teens

NCT ID NCT07455916

Knowledge-focused Sponsor: Wonkwang University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 25, 2026 · Updated 2 times

Summary

This study tested whether an AI-powered smartwatch could help teenagers and young adults with mental health conditions stick to their medication schedule. Researchers compared medication adherence in 78 people who wore the watch to those who did not. The goal was to see if the watch's reminders and tracking improved how often they took their pills as prescribed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

85 people

The number who actually took part.

Started

Dec 2022

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 12 years or older * Receiving outpatient psychiatric care at Wonkwang University Hospital * Receiving at least one regularly prescribed psychotropic medication * Willing and able to wear the study smartwatch and complete the study assessments * Able to provide written informed consent; for minors, written assent and written consent from a parent or legal guardian were required Exclusion Criteria: * Diagnosed congenital genetic disorder * Clear history of acquired brain injury * Seizure disorder or another neurological condition that could interfere with study participation * Psychotic symptoms, aggression, or behavioral instability severe enough to prevent safe and stable smartwatch use or create a substantial risk of device damage

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence to care are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Medication Adherence mental disorder mood disorder psychiatric disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence to care Digital health Medication adherence Mental disease Mental disorders Mood disorders

Contacts and locations

Locations

  • Wonkwang University Hospital

    Iksan, Jeollabuk-do, 54538, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.